Targeted inhibition of a 'signal jammer' protein may improve tumor response to immunotherapy
Targeted inhibition of a "signal jammer" protein may improve how tumors respond to immunotherapy. Published today in Nature, a new study demonstrates how some cancer cells use the protein ...
Medscape2h
Skin Cancer Outcomes Worsen With Rise in Risk Factors
The greater the number of risk factors in patients with cutaneous squamous cell carcinoma, the higher the likelihood of poor ...
Illuminating the immune response to aberrant DNA
Our cells harbor a DNA detector termed cGAS to inform the immune system of viral and bacterial infections, cell death, as ...
My baby was unsettled, restless and impossible to soothe. I tried everything, but nothing worked... until I met a doctor with an incredible solution that made me a be…
What if your child's epic tantrums aren't your fault - or theirs? What if the reason they struggle to sleep, act up around ...
29-Year-Old Mom with Cancer Recalls Telling Her 4 Kids About Fatal Prognosis: 'I Remember Them Screaming'
Ashleigh Ellerton, is just 29 and trying to make memories with her four children, saying she hopes they know “I fought as ...
‘Show up and share’: How one UCLA ICU helps patients and staff live with dying
Honoring a patient’s death can be life-affirming. That’s the ethos behind an UCLA initiative to support patients, their ...
Scoring system helps predict risk of developing cancer from common blood disorder in older adults
A team of international scientists has developed a method to predict the risk of developing cancer from a blood disorder common in older adults, according to a study published in the journal Blood.